US FDA Staff Question Data On Cepheid Cancer Test
WASHINGTON, Nov 14 (Reuters) - Data on Cepheid Inc.'s lab test to quickly detect breast cancer that has spread to lymph nodes lacks long term information on survival, U.S. regulatory staff said in documents released on Wednesday.